Sono-Tek Corporation — FY2019 Form 10-K
Reporting period: Fiscal year ended February 28, 2019. Although the request identifies “2018 Q4,” this filing is an annual report for FY2019, not a standalone quarterly report. Sono-Tek designs and manufactures ultrasonic coating systems and related components for electronics, medical, alternative-energy, industrial and other markets.
Financial performance and liquidity
| Metric | FY2019 | FY2018 |
|---|---|---|
| Net sales | $11.610 million | $11.008 million |
| Gross profit / margin | $5.248 million / 45.2% | $5.296 million / 48.1% |
| Operating income / margin | $82,487 / 0.7% | $381,617 / 3.5% |
| Net income | $161,587 | $368,207 |
| Basic and diluted EPS | $0.01 | $0.02 |
| Cash from operating activities | $(108,980) | $1.802 million |
- Revenue increased approximately 5.5%. Growth in multi-axis coating systems and OEM systems offset a sharp decline in integrated coating systems.
- Gross margin fell 290 basis points. Management attributed pressure to aggressive pricing to establish a position in China’s fuel-cell market and increased outsourced content in more complex systems.
- Operating expenses rose 5% to $5.166 million, including higher spending on sales personnel, engineering and product development.
- Cash and marketable securities totaled $5.510 million at year-end, versus $6.422 million a year earlier. Working capital was $6.424 million, down from $6.560 million.
- Capital expenditures were $547,251, including $337,000 for CNC equipment. Operating cash use reflected higher receivables, inventories and prepaid expenses, partly offset by increased customer deposits.
- Long-term debt was $870,531, secured by the company’s land and buildings; $162,816 was due within one year. The $1.5 million revolving line had no borrowings, but $808,000 was committed to customer letters of credit, leaving $692,000 available. Management described debt as approximately 10% of total capitalization.
Material changes and business developments
- Sales outside the U.S. and Canada rose to approximately 65% of revenue from 56%. Asia-Pacific sales increased 48%, primarily on demand from China in alternative energy and medical applications; U.S. and Canada sales declined 16%.
- Alternative-energy revenue increased 17%, while industrial revenue declined 21%. Electronics/microelectronics and medical revenue rose 6% and 3%, respectively.
- Year-end backlog reached a record $3.038 million, up 145% from $1.238 million. The filing cites a complex electronics/microelectronics order and continued demand in alternative energy and medical markets.
- One customer represented 14% of FY2019 sales. Two customers accounted for 41% of year-end accounts receivable.
Outlook, risks and unusual items
- Management expected all year-end backlog to ship in FY2020 and forecast sales growth of 15%–20%, with higher volume expected to improve margins and earnings. The outlook included a $1.65 million order for a newly introduced Robotic Coating Platform.
- Management’s growth case for China fuel cells depends on market development, production volumes and future manufacturing cost reductions; the company acknowledged that its pricing strategy weighed on current margins.
- The company cautioned that order flow and shipments can vary substantially quarter to quarter, especially as it sells more complex, high-value systems. Other stated uncertainties include market acceptance and timely development of products, competition, economic and trade conditions, capacity, financing and patent enforcement.
- FY2019 included a $100,184 unrealized loss on marketable securities, recognized in net income following adoption of a new accounting standard. The filing reports no material commitments or contingencies, no legal proceedings and no off-balance-sheet arrangements.
- The independent auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor did not express an opinion on internal control.
Important facts for investors to verify
- Whether the $3.038 million backlog shipped as expected and translated into the forecast FY2020 revenue growth.
- Whether fuel-cell market growth and production scale delivered the anticipated manufacturing efficiencies and margin recovery.
- Customer concentration, collection of receivables and the working-capital demands of larger, customized orders.
- How the $1.65 million robotic-platform order and broader product mix affected sales, margins and cash generation.
- The filing’s MD&A contains a comparison-date typo in its cash discussion; audited balance-sheet figures show $5.510 million at February 28, 2019 versus $6.422 million at February 28, 2018.